Related Experiment Video
Updated: Aug 11, 2026

Methodology for Accurate Detection of Mitochondrial DNA Methylation
Published on: May 20, 2018
1-Methyl-4-phenylpyridinium ion (MPP+) selectively inhibits the replication of mitochondrial DNA
1Department of Biochemistry, Kyushu University Faculty of Medicine, Fukuoka, Japan.
Abstract:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine is known to cause Parkinsonism in its neurotoxic form, 1-methyl-4-phenylpyridinium ion (MPP+). We have previously reported that MPP+ decreases the content of mitochondrial DNA (mtDNA) independently of the inhibition of complex I in human cells [Miyako, K., Kai, Y., Irie, T., Takeshige, K., and Kang, D. (1997) J. Biol. Chem. 272, 9605-9608]. Here we study the mechanism causing the decrease in mtDNA. MPP+ inhibits the incorporation of 5-bromo-2'-deoxyuridine into mtDNA but not into nuclear DNA, indicating that MPP+ inhibits the replication of mtDNA but not that of the nuclear genome. The replication of mtDNA is initiated by the synthesis of the heavy strand switched from the transcription of the light strand. MPP+ decreases the nascent heavy strands per mtDNA and increases the transcript of the ND6 gene, encoded on light strand, per mtDNA. The amount of mitochondrial transcription factor A is not decreased. These data suggest that the transcription is not inhibited and therefore the transition from transcription to replication of mtDNA is lowered in the MPP+-treated cells. Electron microscopy shows that the number of mitochondria is not decreased in the MPP+-treated cells, suggesting that MPP+ does not affect the overall biogenesis of mitochondria. Thus, MPP+ selectively inhibits the replication of mtDNA.
Insights
The neurotoxin 1-methyl-4-phenylpyridinium ion (MPP+) selectively inhibits mitochondrial DNA (mtDNA) replication, not its transcription or overall biogenesis. This finding clarifies a key mechanism by which MPP+ induces Parkinsonism.
Area of Science:
- Biochemistry
- Neuroscience
- Cell Biology
Background:
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) metabolite, 1-methyl-4-phenylpyridinium ion (MPP+), is a known neurotoxin causing Parkinsonism.
- Previous studies showed MPP+ reduces mitochondrial DNA (mtDNA) content independently of Complex I inhibition.
Purpose of the Study:
- To elucidate the mechanism by which MPP+ decreases mtDNA content.
- To investigate the selective effects of MPP+ on mtDNA replication and transcription.
Main Methods:
- Assay of 5-bromo-2'-deoxyuridine incorporation into mtDNA and nuclear DNA.
- Quantification of nascent heavy strands and ND6 gene transcripts per mtDNA.
- Measurement of mitochondrial transcription factor A levels.
- Electron microscopy for mitochondrial morphology and number.
Main Results:
- MPP+ specifically inhibited the incorporation of 5-bromo-2'-deoxyuridine into mtDNA, but not nuclear DNA, indicating selective inhibition of mtDNA replication.
- MPP+ decreased nascent heavy strands per mtDNA while increasing ND6 gene transcription per mtDNA.
- Mitochondrial transcription factor A levels remained unchanged, and mitochondrial biogenesis was unaffected.
- These results suggest a lowered transition from transcription to replication of mtDNA.
Conclusions:
- MPP+ selectively inhibits the replication of mitochondrial DNA.
- The neurotoxic effect of MPP+ involves the disruption of mtDNA replication, not transcription or mitochondrial biogenesis.
- This provides a clearer understanding of the molecular mechanisms underlying MPP+-induced neurotoxicity.
Related Concept Videos
Negative Regulator Molecules
Animal Mitochondrial Genetics
Restarting Stalled Replication Forks
ATP Synthase: Mechanism
Inhibitors of Bacterial DNA Synthesis

